- Research works
- 68 ▼ 45% vs 2013–17
- Citations
- 11k 156.7 per fractional work
- Top-10% rate
- 38.0% record average 16.5%
- Open access
- 69% world 28%
Not ranked overall: Illumina (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.1×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.1×
- Economics, Econometrics and Finance 2.1×
- Medicine 1.9×
- Immunology and Microbiology 1.2×
- Nursing 1.1×
- Earth and Planetary Sciences 1.1×
- Agricultural and Biological Sciences 0.8×
- Physics and Astronomy 0.7×
- Engineering 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Computer Science 0.4×
- Psychology 0.4×
- Health Professions 0.2×
- Materials Science 0.1×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Neuroscience 0.0×
Which keywords describe research at Illumina (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Cell-Free DNA, Targeted Therapy, Genomic Instability, Cancer Genomics, Mutational Signatures, RNA-Seq, Phylogenetic Analysis and genome annotation.
- Suffix Arrays
- Film Industry
- Box Office
- Molecular Characterization
- Therapy
- Haplotype Mapping
- Genetic Diversity
- Epigenetic Regulation
- Population Genetics
- Maternal Plasma DNA Sequencing
- Prenatal Diagnosis
- Sequence Interpretation
- Genetic Variants
- Gene Expression
- Neurodevelopmental Disorders
- Genomic Rearrangements
- genome annotation
- Phylogenetic Analysis
- Cancer Genomics
- Targeted Therapy
- Cell-Free DNA
- Genomic Instability
- Mutational Signatures
- RNA-Seq
- sequence alignment
- Copy Number Variation
- Structural Variation
- Epidemiology
- Clinical Genomics
- Genomic Sequencing
- Aneuploidy Screening
- Genetic Variation
- Prognostic Factors
- Genome-Wide Association
- Immunotherapy
- Mendelian Randomization
- DNA Methylation
- Nighttime Light Data
- Compression
- Genetic Testing
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cell-Free DNA8▲ 130×2 topics
- Targeted Therapy6▲ 41×2 topics
- Genomic Instability6▲ 68×2 topics
- Cancer Genomics6▲ 158×1 topic
- Mutational Signatures6▲ 158×1 topic
- Phylogenetic Analysis4▲ 17×3 topics
- RNA-Seq4▲ 70×2 topics
- genome annotation4▲ 84×1 topic
- sequence alignment4▲ 84×1 topic
- Genomic Rearrangements4▲ 226×2 topics
- Copy Number Variation4▲ 234×1 topic
- Neurodevelopmental Disorders4▲ 37×2 topics
- Structural Variation4▲ 234×1 topic
- Gene Expression3▲ 8.0×8 topics
- Epidemiology3▲ 1.17×33 topics
- Genetic Variants3▲ 22×4 topics
- Clinical Genomics3▲ 175×1 topic
- Sequence Interpretation3▲ 175×1 topic
- Genomic Sequencing3▲ 26×3 topics
- Prenatal Diagnosis2▲ 21×4 topics
- Aneuploidy Screening2▲ 88×1 topic
- Maternal Plasma DNA Sequencing2▲ 88×1 topic
- Genetic Variation2▲ 9.3×6 topics
- Population Genetics2▲ 18×4 topics
- Prognostic Factors2▲ 6.1×5 topics
- Epigenetic Regulation2▲ 12×3 topics
- Genome-Wide Association2▲ 32×2 topics
- Genetic Diversity2▲ 4.8×6 topics
- Immunotherapy2▲ 3.7×11 topics
- Haplotype Mapping1▲ 78×1 topic
- Mendelian Randomization1▲ 78×1 topic
- Therapy1▲ 9.8×4 topics
- DNA Methylation1▲ 16×2 topics
- Molecular Characterization1▲ 9.2×3 topics
- Nighttime Light Data1▲ 78×1 topic
- Box Office1▲ 72×1 topic
- Compression1▲ 33×1 topic
- Film Industry1▲ 72×1 topic
- Genetic Testing1▲ 9.6×3 topics
- Suffix Arrays1▲ 47×1 topic
Which research topics does Illumina (United Kingdom) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Acute Myeloid Leukemia Research, Genomic variations and chromosomal abnormalities and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 1 works
- 2 Acute Myeloid Leukemia Research Hematology 1 works
- 3 Genomic variations and chromosomal abnormalities Genetics 0 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 5 Genomics and Rare Diseases Genetics 0 works
- 6 Advanced Battery Technologies Research Automotive Engineering 0 works
- 7 Advancements in Battery Materials Electrical and Electronic Engineering 0 works
- 8 Genomics and Phylogenetic Studies Molecular Biology 0 works
- 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 10 Advanced battery technologies research Electrical and Electronic Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Illumina (United Kingdom)'s research output changed?
Output in 2018–2022 was 45% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- University of Cambridge
- Addenbrooke's Hospital
- MRC Laboratory of Molecular Biology
- Anglia Ruskin University
- AstraZeneca (United Kingdom)
- Microsoft Research (United Kingdom)
- British Antarctic Survey
- Cambridge University Hospitals NHS Foundation Trust
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.